O'Neill Clodagh P, Gilligan Katie E, Dwyer Róisín M
Discipline of Surgery, Lambe Institute for Translational Research, National University of Ireland Galway (NUIG), Galway H91 YR71, Ireland.
Cancers (Basel). 2019 Jan 24;11(2):136. doi: 10.3390/cancers11020136.
Extracellular vesicles (EVs) are nanosized particles released by all cells that have been heralded as novel regulators of cell-to-cell communication. It is becoming increasingly clear that in response to a variety of stress conditions, cells employ EV-mediated intercellular communication to transmit a pro-survival message in the tumor microenvironment and beyond, supporting evasion of cell death and transmitting resistance to therapy. Understanding changes in EV cargo and secretion pattern during cell stress may uncover novel, targetable mechanisms underlying disease progression, metastasis and resistance to therapy. Further, the profile of EVs released into the circulation may provide a circulating biomarker predictive of response to therapy and indicative of microenvironmental conditions linked to disease progression, such as hypoxia. Continued progress in this exciting and rapidly expanding field of research will be dependent upon widespread adoption of transparent reporting standards and implementation of guidelines to establish a consensus on methods of EV isolation, characterisation and nomenclature employed.
细胞外囊泡(EVs)是所有细胞释放的纳米级颗粒,被誉为细胞间通讯的新型调节因子。越来越清楚的是,响应各种应激条件时,细胞利用EV介导的细胞间通讯在肿瘤微环境及其他环境中传递促生存信息,支持逃避细胞死亡并传递对治疗的抗性。了解细胞应激期间EV货物和分泌模式的变化可能揭示疾病进展、转移和治疗抗性背后新的、可靶向的机制。此外,释放到循环中的EV谱可能提供一种循环生物标志物,预测对治疗的反应并指示与疾病进展相关的微环境条件,如缺氧。在这个令人兴奋且迅速扩展的研究领域取得持续进展将取决于广泛采用透明的报告标准以及实施指南,以就所采用的EV分离、表征和命名方法达成共识。